ACON (Aclarion) Notes Receivable: $0.00 Mil (As of Mar. 2026)


ACON Aclarion Inc ACON
26 GF Score
Price $2.81
! 2 Warning Signs
View Full Analysis

What is Aclarion Notes Receivable?

Aclarion ACON +6.18% 26 Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus rates ACON with a GF Score™ of 26/100. The stock has 2 warning signs investors should review.

Aclarion's Notes Receivable for the quarter that ended in Mar. 2026 was $0.00 Mil.

Aclarion Notes Receivable Historical Data

* Premium members only.

The historical data trend for Aclarion's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aclarion Notes Receivable Chart

Aclarion Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Aclarion Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ACON
26GF Score
Aclarion Inc ACON
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aclarion Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Aclarion (ACON) has a Notes Receivable of $0.00 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Aclarion and its competitors.
Is Aclarion's Notes Receivable too high?
Aclarion's current Notes Receivable is $0.00 Mil. Overall, Aclarion has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Aclarion's Notes Receivable compare to BRGX and MGRX?
Aclarion's Notes Receivable of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Aclarion and its competitors. Aclarion's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aclarion stock overvalued right now?
Aclarion (ACON) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Aclarion's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Aclarion (ACON), the current Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aclarion Business Description

Other Exchanges IT20:Germany
Address 8181 Arista Place, Suite 100, Broomfield, CO, USA, 80021
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
26GF Score

Get the complete analysis for ACON

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.81
Price